logo

For the Inventor, By the Inventor

The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 9981029 B1

PDFFull Text
Date of Patent:
May. 29, 2018

Filed:

Dec. 05, 2013

Multivalent pneumococcal polysaccharide-protein conjugate composition

Applicant:

SK Chemicals Co., Ltd., Seongnam-si, Gyeonggi-do, KR;

Inventors:

Mahn-Hoon Park, Yongin-si, KR;

Hun Kim, Suwon-si, KR;

Ji-Hye Yang, Seoul, KR;

Seon-Young Yang, Incheon, KR;

Myeong-Ju Noh, Seoul, KR;

Su-Jin Park, Seongnam-si, KR;

Jin-Hwan Shin, Seoul, KR;

Assignee:

SK Chemical Co., Ltd., Gyeonggi-do, KR;

Attorney:

Buchanan Ingersoll & Rooney, PC

Primary Examiner:

Mary Maille Lyons

Int. Cl.
CPC ...
A61K 39/09 (2006.01); A61K 9/00 (2006.01); A61K 47/02 (2006.01); A61K 47/12 (2006.01); A61K 47/26 (2006.01); A61K 39/116 (2006.01); A61K 39/39 (2006.01); A61K 47/64 (2017.01); A61K 39/00 (2006.01);
U.S. Cl.
CPC ...
A61K 39/092 (2013.01); A61K 9/0019 (2013.01); A61K 39/116 (2013.01); A61K 39/39 (2013.01); A61K 47/02 (2013.01); A61K 47/12 (2013.01); A61K 47/26 (2013.01); A61K 47/646 (2017.08); A61K 47/6415 (2017.08); A61K 2039/545 (2013.01); A61K 2039/55505 (2013.01); A61K 2039/6031 (2013.01); A61K 2039/6037 (2013.01); A61K 2039/70 (2013.01);
Abstract

Provided is an immunogenic composition comprising 13 different polysaccharide-protein conjugates. Each of the conjugates comprises a capsular polysaccharide prepared from a different serotypeconjugated to a carrier protein, that is, 12 serotypes selected from the group consisting of 1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A, 19F and 23F and serotype 2 or 9N. The immunogenic composition formulated into a vaccine comprising an aluminum-based adjuvant increases coverage with respect to pneumococcal diseases in infants and children.

Find Patent Forward Citations

Loading…